Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Anpario’s fifth full-year upgrade in a row feeds further gains

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Shares in Anpario (ANP:AIM) are up a portfolio-nourishing 67% over one year, the latest upward spike triggered by a fifth upgrade in a row (10 January) to full-year 2024 guidance from the natural sustainable feed additives supplier.
Following a stronger-than-expected second half, Anpario now expects revenue for the year to December 2024 to be £37.5 million implying 21% year-on-year growth.
Combined with the benefits of high operational gearing and favourable currency swings, this means adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) should come in ahead of the £5.7 million consensus estimate.
Anpario is profiting as food producers around the world transition to natural feed solutions and away from banned additives such as antibiotic growth promoters and as the safety and sustainability of global food production continues to increase.
The Nottinghamshire-based firm is winning market share and widening its moat, since competitors struggle to replicate its science-backed, patented products.
The company’s second-half outperformance was broad-based, albeit largely driven by very strong growth across the Middle East and Africa and a continued recovery across Asia, with recent acquisition Bio-Vet benefiting from greater product demand to support the health of dairy cows affected by avian influenza.
Year-end net cash of £10.5 million should enable the company to invest in innovative natural product solutions, expand its global reach and explore earnings enhancing and complementary acquisitions.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.